US equities
|
MU
$1,065.71
▼-2.05%
NVDA
$236.06
▼-0.59%
PLTR
$199.75
▲+2.90%
SNDK
$1,640.09
▼-3.09%
AMD
$634.89
▼-1.70%
INTC
$109.06
▼-3.58%
META
$722.47
▲+0.16%
SPCX
$164.44
▼-1.89%
MU
$1,065.71
▼-2.05%
NVDA
$236.06
▼-0.59%
PLTR
$199.75
▲+2.90%
SNDK
$1,640.09
▼-3.09%
AMD
$634.89
▼-1.70%
INTC
$109.06
▼-3.58%
META
$722.47
▲+0.16%
SPCX
$164.44
▼-1.89%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Integral Molecular
Recent news which mentions Integral Molecular
Context Therapeutics Partners With Integral Molecular To Develop An Emerging Cancer Drug
November 10, 2022
Tickers
CNTX
Tags
Benzinga
Integral Molecular
General
From
Benzinga